Physician profile
Marc Colmer
NPI 1154376549
$4,840.68
in general payments reported to CMS, 2019-2025
38 companies · $686 in 2025
The $686 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $913 · 2020: $299 · 2021: $494 · 2022: $829 · 2023: $665 · 2024: $955 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,305.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $789.32 | 2019-2025 | |
| Amgen INC. | $702.10 | 2019-2025 | Repatha, Repatha |
| Novo Nordisk INC | $497.91 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $433.58 | 2020-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $431.38 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Watchman |
| Abbott Laboratories | $345.02 | 2019-2024 | Aveir |
| Janssen Pharmaceuticals, INC | $200.57 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $172.31 | 2021-2025 | Verquvo |
| Medtronic, INC. | $143.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.11 | 2019-2025 | Jardiance |
| Biosense Webster, INC. | $105.03 | 2019-2020 | |
| Pfizer INC. | $104.35 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $82.01 | 2022-2024 | Evkeeza |
| Sanofi-Aventis U.S. LLC | $77.66 | 2021-2024 | |
| Kiniksa Pharmaceuticals, LTD. | $68.74 | 2021-2023 | Arcalyst |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $59.30 | 2024-2025 | |
| Philips North America LLC | $45.72 | 2022-2023 | |
| Cvrx, INC. | $44.87 | 2024-2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $40.21 | 2020-2021 | |
| Abiomed | $37.68 | 2025 | |
| Irhythm Technologies, INC. | $32.07 | 2020 | |
| Cardiovascular Systems INC. | $30.10 | 2019 | |
| Biotronik INC. | $29.21 | 2022 | |
| Cardinal Health 200 LLC | $24.82 | 2019 | |
| Glaxosmithkline, LLC. | $22.78 | 2025 | Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $20.12 | 2025 | |
| Lilly USA, LLC | $20.04 | 2025 | Zepbound |
| Alnylam Pharmaceuticals INC. | $18.52 | 2025 | Onpattro |
| Kiniksa Pharmaceuticals International, Plc | $18.26 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $17.07 | 2022 | |
| Medicure Pharma INC. | $15.00 | 2021 | |
| Astellas Pharma US INC | $14.41 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.26 | 2022 | |
| Portola Pharmaceuticals, LLC | $14.22 | 2020 | |
| Arbor Pharmaceuticals, INC. | $14.14 | 2019 | |
| Medtronic Vascular, INC. | $14.05 | 2019 | |
| Gilead Sciences, INC. | $13.63 | 2019 | |
| Chiesi USA, INC. | $13.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Colmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.